Literature DB >> 23949231

Peritonitis in the patient on peritoneal dialysis: does the composition of the dialysis fluid make a difference?

Danica Lam, Joanne M Bargman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23949231      PMCID： PMC3805075          DOI： 10.2215/CJN.07830713

Source DB:  PubMed          Journal:  Clin J Am Soc Nephrol        ISSN： 1555-9041            Impact factor:   8.237


× No keyword cloud information.
  12 in total

1.  Expanding the evidence base in transplantation: the complementary roles of randomized controlled trials and outcomes research.

Authors:  Steven K Takemoto; Wolfgang Arns; Suphamai Bunnapradist; Louis P Garrison; Lluis Guirado; Zoltan Kalo; Gabriel Oniscu; Gerhard Opelz; Maria Piera Scolari; Sergio Stefoni; Magdi Yaqoob; Daniel C Brennan
Journal:  Transplantation       Date:  2008-07-15       Impact factor: 4.939

2.  Effects of peritoneal dialysis solutions low in GDPs on peritonitis and exit-site infection rates.

Authors:  Jürgen Furkert; Martin Zeier; Vedat Schwenger
Journal:  Perit Dial Int       Date:  2008 Nov-Dec       Impact factor: 1.756

3.  Effects of conventional and new peritoneal dialysis fluids on leukocyte recruitment in the rat peritoneal membrane.

Authors:  Siska Mortier; An S De Vriese; Rachel M McLoughlin; Nicholas Topley; Thomas P Schaub; Jutta Passlick-Deetjen; Norbert H Lameire
Journal:  J Am Soc Nephrol       Date:  2003-05       Impact factor: 10.121

4.  Use of pure bicarbonate-buffered peritoneal dialysis fluid reduces the incidence of CAPD peritonitis.

Authors:  Jesús Montenegro; Ramón Saracho; Isabel Gallardo; Isabel Martínez; Rosa Muñoz; Nuria Quintanilla
Journal:  Nephrol Dial Transplant       Date:  2007-04-03       Impact factor: 5.992

5.  Superior patient survival for continuous ambulatory peritoneal dialysis patients treated with a peritoneal dialysis fluid with neutral pH and low glucose degradation product concentration (Balance).

Authors:  Ho Yung Lee; Hyeong Cheon Park; Bo Jeung Seo; Jun Young Do; Sung Ro Yun; Hyun Yong Song; Yeong Hoon Kim; Yong Lim Kim; Dae Joong Kim; Yong Soo Kim; Curie Ahn; Moon Jae Kim; Sug Kyun Shin
Journal:  Perit Dial Int       Date:  2005 May-Jun       Impact factor: 1.756

Review 6.  The biocompatibility of neutral pH, low-GDP peritoneal dialysis solutions: benefit at bench, bedside, or both?

Authors:  Jeffrey Perl; Sharon J Nessim; Joanne M Bargman
Journal:  Kidney Int       Date:  2011-01-19       Impact factor: 10.612

7.  3,4-di-deoxyglucosone-3-ene promotes leukocyte apoptosis.

Authors:  Marina Penélope Catalan; Beatriz Santamaría; Ana Reyero; Arturo Ortiz; Jesús Egido; Alberto Ortiz
Journal:  Kidney Int       Date:  2005-09       Impact factor: 10.612

8.  The Euro-Balance Trial: the effect of a new biocompatible peritoneal dialysis fluid (balance) on the peritoneal membrane.

Authors:  John D Williams; Nicholas Topley; Kathrine J Craig; Ruth K Mackenzie; Monika Pischetsrieder; Cristina Lage; Jutta Passlick-Deetjen
Journal:  Kidney Int       Date:  2004-07       Impact factor: 10.612

Review 9.  Cancer antigen 125 as a biomarker in peritoneal dialysis: mesothelial cell health or death?

Authors:  Harpaul Cheema; Joanne M Bargman
Journal:  Perit Dial Int       Date:  2013 Jul-Aug       Impact factor: 1.756

10.  Association of biocompatible peritoneal dialysis solutions with peritonitis risk, treatment, and outcomes.

Authors:  Yeoungjee Cho; Sunil V Badve; Carmel M Hawley; Stephen P McDonald; Fiona G Brown; Neil Boudville; Kym M Bannister; Philip A Clayton; David W Johnson
Journal:  Clin J Am Soc Nephrol       Date:  2013-08-15       Impact factor: 8.237
View more
  1 in total

1.  Differences in peritoneal response after exposure to low-GDP bicarbonate/lactate-buffered dialysis solution compared to conventional dialysis solution in a uremic mouse model.

Authors:  M Vila Cuenca; E D Keuning; W Talhout; N J Paauw; F J van Ittersum; P M Ter Wee; R H J Beelen; M G Vervloet; E Ferrantelli
Journal:  Int Urol Nephrol       Date:  2018-05-04       Impact factor: 2.370
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.